2024
White-matter changes associated with a synergetic treatment for myalgic encephalomyelitis/chronic fatigue syndrome
Mohamed A, do Campo J, Del Fante P, Kwiatek R, Calhoun V, Shan Z. White-matter changes associated with a synergetic treatment for myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue Biomedicine Health & Behavior 2024, ahead-of-print: 1-11. DOI: 10.1080/21641846.2024.2367921.Peer-Reviewed Original ResearchMyalgic encephalomyelitis/chronic fatigue syndromeLow-dose naltrexoneFatigue syndromeWhite-matter tractsPre-treatment baselineDebilitating chronic illnessDeficit symptomsME/CFS patientsDiffusion-weighted imaging dataReducing depressionTreating ME/CFSSymptom improvementFractional anisotropyOff-label treatmentWhite-matter changesNaltrexoneNICE guidelinesPost-treatmentSymptomsME/CFSNeuroimaging characteristicsClinical measuresChronic illnessControl groupRandomized controlled trials
2023
A Deep Learning Approach for Psychosis Spectrum Label Noise Detection from Multimodal Neuroimaging Data
Rokham H, Falakshahi H, Calhoun V. A Deep Learning Approach for Psychosis Spectrum Label Noise Detection from Multimodal Neuroimaging Data. Annual International Conference Of The IEEE Engineering In Medicine And Biology Society (EMBC) 2023, 00: 1-4. PMID: 38082903, DOI: 10.1109/embc40787.2023.10339949.Peer-Reviewed Original ResearchConceptsStructural MRI dataResting-state functional MRI dataFunctional MRI dataFunctional magnetic resonance imaging dataMRI dataMagnetic resonance imaging dataSchizophrenia patientsFunctional connectivity featuresBrain imaging modalitiesMental disordersNeuroimaging dataNeuroimaging techniquesBorderline subjectsHealthy control groupSchizophrenia datasetSchizophreniaConnectivity featuresBrainPsychosisMoodNosologyControl groupDisordersLabel noiseSubjects